Finance

Lists
Why is ADCT up 4,98%?
Dive Deeper
ADCT:NYSE
ADC Therapeutics SA
1,48 US$
+4,98%
(+0,070) 1D
19 ოქტ, 14:42:10 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADCT...
Open
1,40 US$
High
1,49 US$
Low
1,39 US$
Mkt. cap
188,31 მლნ.
Avg. vol.
1,67 მლნ.
Volume
319,53 ათ.
52-wk high
4,98 US$
52-wk low
0,78 US$
EPS
-0,73 US$
Beta
1,86
Shares outstanding
127,67 მლნ.
No. of employees
191
Open
1,40 US$
High
1,49 US$
Low
1,39 US$
Mkt. cap
188,31 მლნ.
Avg. vol.
1,67 მლნ.
Volume
319,53 ათ.
52-wk high
4,98 US$
52-wk low
0,78 US$
EPS
-0,73 US$
Beta
1,86
Shares outstanding
127,67 მლნ.
No. of employees
191
News stories
From web sources and news partners
About ADC Therapeutics SA
CEO-
Employees191
Founded2011
Headquarters-
Sector-
Websiteadctherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to ADCT in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ADCT in the last 3 months.
Highest
Current 1,48 US$
5,00 US$ (+238,98%)
Average
3,50 US$ (+137,29%)
Lowest
2,00 US$ (+35,59%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Hold
Maintained
2,00 US$
+35,6%
10/08/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
5,00 US$
+239%
08/14/2026
Robert Burns
H.C. Wainwright
Hold
Downgraded
-
-
06/08/2026
Sudan Loganathan
Stephens
Buy
Reiterated
5,00 US$
+239%
06/04/2026
Last report
13 აგვ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (USD)
19,25 მლნ. / 18,90 მლნ.
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
16,43 მლნ.
23,06 მლნ.
20,85 მლნ.
19,25 მლნ.
Cost of goods sold
28,00 მლნ.
17,60 მლნ.
23,49 მლნ.
19,72 მლნ.
Cost of revenue
28,00 მლნ.
17,60 მლნ.
23,49 მლნ.
19,72 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,01 მლნ.
21,44 მლნ.
22,60 მლნ.
22,27 მლნ.
Operating expense
19,01 მლნ.
21,44 მლნ.
22,60 მლნ.
22,27 მლნ.
Total operating expenses
47,02 მლნ.
39,04 მლნ.
46,10 მლნ.
41,99 მლნ.
Operating income
-30,59 მლნ.
-15,98 მლნ.
-25,24 მლნ.
-22,74 მლნ.
Other non operating income
587,00 ათ.
21,84 მლნ.
2,30 მლნ.
20,66 მლნ.
EBT including unusual items
-40,97 მლნ.
-6,81 მლნ.
-32,97 მლნ.
-16,56 მლნ.
EBT excluding unusual items
-40,59 მლნ.
-4,88 მლნ.
-32,97 მლნ.
-13,89 მლნ.
Income tax expense
-
-404,00 ათ.
-
-
Effective tax rate
-
5,93%
-
-
Other operating expenses
-
-
-
-
Net income
-40,97 მლნ.
-6,41 მლნ.
-32,97 მლნ.
-16,56 მლნ.
Net profit margin
-249,38%
-27,80%
-158,11%
-86,06%
Earnings per share
-
-
-
-
Interest and investment income
2,47 მლნ.
2,35 მლნ.
1,99 მლნ.
1,82 მლნ.
Interest expense
-13,39 მლნ.
-13,01 მლნ.
-12,35 მლნ.
-13,51 მლნ.
Net interest expenses
-10,92 მლნ.
-10,66 მლნ.
-10,36 მლნ.
-11,69 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,59 მლნ.
-15,98 მლნ.
-25,07 მლნ.
-22,56 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები